CNS Pharmaceuticals (CNSP) Enterprise Value
Price: $1.21
Market Cap: $3.56M
Avg Volume: 540.20K
Market Cap: $3.56M
Avg Volume: 540.20K
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Enterprise Value Summary (Quarterly)
According to CNS Pharmaceuticals's latest quarterly financial reports:
- The enterprise value (EV) is -3.83M, which includes the market capitalization, debt, and subtracts cash and cash equivalents. EV provides a more comprehensive measure of a company's total value.
- The market capitalization is 2.30M, which is calculated by multiplying the current share price by the total number of outstanding shares.
- The stock price is $6.02, with 382.24K shares outstanding.
- The company has 6.46M in cash and cash equivalents and 326.07K in total debt.
Enterprise Value (EV) Formula:
EV = Market Cap + Total Debt - Cash and Cash Equivalents
Enterprise value is often used instead of market cap because it provides a more accurate valuation of a company by including debt and subtracting cash, giving a fuller picture of the company's total value.
Enterprise Value
$-3.83M
Market Cap
$2.30M
Total Debt
$326.07K
Cash and Equivalents
$6.46M
Historical Enterprise Value
CNS Pharmaceuticals Historical Enterprise Values
The table below shows various enterprise value metrics for each quarter, with the latest data available for 2024-12-31.
| Date | Enterprise Value | EV Change (%) | Stock Price | Number of Shares | Market Cap | Cash & Equivalents | Total Debt |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | $-3.83M | -102.78% | $6.02 | 382.24K | $2.30M | $6.46M | $326.07K |
| September 30, 2024 | $137.90M | -96.00% | $6.53 | 22.18M | $144.84M | $6.97M | $31.19K |
| June 30, 2024 | $3.45B | -93.80% | $71 | 48.59M | $3.45B | $1.49M | $123.25K |
| March 31, 2024 | $55.58B | -71.67% | $899.5 | 61.80M | $55.58B | $815.23K | $213.10K |
| December 31, 2023 | $196.20B | -17.59% | $3175 | 61.80M | $196.20B | $548.72K | $300.81K |
| September 30, 2023 | $238.09B | -44.93% | $2850 | 83.54M | $238.09B | $909.55K | $41.90K |
| June 30, 2023 | $432.31B | 353.54% | $5575 | 77.55M | $432.32B | $4.28M | $166.40K |
| March 31, 2023 | $95.32B | -46.47% | $2500 | 38.13M | $95.33B | $5.11M | $289.07K |
| December 31, 2022 | $178.05B | -48.99% | $6000 | 29.68M | $178.06B | $10.06M | $409.97K |
| September 30, 2022 | $349.04B | -36.07% | $13425 | 26.00M | $349.05B | $7.03M | $39.26K |
| June 30, 2022 | $545.99B | -14.60% | $21000 | 26.00M | $546.00B | $8.96M | $156.40K |
| March 31, 2022 | $639.36B | -28.61% | $25575 | 25.00M | $639.38B | $12.44M | $272.57K |
| December 31, 2021 | $895.56B | -55.48% | $52680 | 17.00M | $895.56B | $5.00M | $387.79K |
| September 30, 2021 | $2.01T | -14.48% | $111750 | 18.00M | $2.01T | $8.33M | $44.63K |
| June 30, 2021 | $2.35T | -17.99% | $147000 | 16.00M | $2.35T | $6.89M | $177.58K |
| March 31, 2021 | $2.87T | 95.30% | $179250 | 16.00M | $2.87T | $11.08M | $309.13K |
| December 31, 2020 | $1.47T | 11.25% | $133500 | 11.00M | $1.47T | $14.04M | $439.29K |
| September 30, 2020 | $1.32T | -17.76% | $132000 | 10.00M | $1.32T | $1.31M | $- |
| June 30, 2020 | $1.60T | -7.07% | $160500 | 10.00M | $1.60T | $2.63M | $- |
| March 31, 2020 | $1.73T | -46.84% | $157500 | 10.97M | $1.73T | $5.38M | $- |
| December 31, 2019 | $3.25T | -13.57% | $296250 | 10.97M | $3.25T | $7.24M | $- |
| September 30, 2019 | $3.76T | 0.00% | $342750 | 10.97M | $3.76T | $630.11K | $300.00K |
| June 30, 2019 | $3.76T | -0.00% | $342750 | 10.97M | $3.76T | $911.93K | $300.00K |
| March 31, 2019 | $3.76T | 0.00% | $342750 | 10.97M | $3.76T | $155.02K | $290.83K |
| December 31, 2018 | $3.76T | 0.00% | $342750 | 10.97M | $3.76T | $282.74K | $316.92K |
| September 30, 2018 | $3.76T | 0.00% | $342750 | 10.97M | $3.76T | $- | $- |
| June 30, 2018 | $3.76T | 0.00% | $342750 | 10.97M | $3.76T | $380.69K | $374.04K |
| March 31, 2018 | $3.76T | - | $342750 | 10.97M | $3.76T | $242.69K | $121.83K |
Related Metrics
Explore detailed financial metrics and analysis for CNSP.